Your browser doesn't support javascript.
loading
The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy.
Atia, Amany Aa; Ashour, Rehab H; Zaki, Marwa Maf; Rahman, Karawan Ma; Ramadan, Nehal M.
Afiliación
  • Atia AA; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, 60 El-Gomhoria Street, Mansoura, Al-Dakahlia, 35516, Egypt.
  • Ashour RH; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, 60 El-Gomhoria Street, Mansoura, Al-Dakahlia, 35516, Egypt.
  • Zaki MM; Department of Pathology, Faculty of Medicine, Mansoura University, 60 El-Gomhoria Street, Mansoura, Al-Dakahlia, 35516, Egypt.
  • Rahman KM; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, 60 El-Gomhoria Street, Mansoura, Al-Dakahlia, 35516, Egypt.
  • Ramadan NM; Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, 60 El-Gomhoria Street, Mansoura, Al-Dakahlia, 35516, Egypt. nehalpharma@mans.edu.eg.
Psychopharmacology (Berl) ; 240(6): 1313-1332, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37133558
ABSTRACT
RATIONALE Risperidone is the first antipsychotic to be approved by Food and Drug Administration (FDA) for treating autism spectrum disorder (ASD). The potential efficacy of metformin in preventing and/or controlling ASD behavioral deficits was also recently reported. Suppression of hippocampus autophagy was suggested as a potential pathologic mechanism in ASD.

OBJECTIVES:

Is metformin's ability to improve ASD clinical phenotype driven by its autophagy-enhancing properties? And does hippocampus autophagy enhancement underlie risperidone's efficacy as well? Both questions are yet to be answered.

METHODS:

The effectiveness of metformin on alleviation of ASD-like behavioral deficits in adolescent rats exposed prenatally to valproic acid (VPA) was compared to that of risperidone. The potential modulatory effects of risperidone on hippocampal autophagic activity were also assessed and compared to those of metformin.

RESULTS:

Male offspring exposed to VPA during gestation exhibited marked anxiety, social impairment and aggravation of stereotyped grooming; such deficits were efficiently rescued by postnatal risperidone or metformin therapy. This autistic phenotype was associated with suppressed hippocampal autophagy; as evidenced by reduced gene/dendritic protein expression of LC3B (microtubule-associated proteins 1 light chain 3B) and increased somatic P62 (Sequestosome 1) protein aggregates. Interestingly, compared to risperidone, the effectiveness of metformin in controlling ASD symptoms and improving hippocampal neuronal survival was well correlated to its ability to markedly induce pyramidal neuronal LC3B expression while lowering P62 accumulation.

CONCLUSIONS:

Our work highlights, for the first time, positive modulation of hippocampus autophagy as potential mechanism underlying improvements in autistic behaviors, observed with metformin, as well as risperidone, therapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Efectos Tardíos de la Exposición Prenatal / Trastorno Autístico / Trastorno del Espectro Autista Límite: Animals / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Año: 2023 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Asunto principal: Efectos Tardíos de la Exposición Prenatal / Trastorno Autístico / Trastorno del Espectro Autista Límite: Animals / Female / Humans / Male Idioma: En Revista: Psychopharmacology (Berl) Año: 2023 Tipo del documento: Article País de afiliación: Egipto
...